New USP General Chapter <800> Hazardous Drugs—Handling in Healthcare Settings provides consistent standards for the handling of hazardous drugs in healthcare settings to help minimize exposure to healthcare workers, avoid unintended and repeated exposures, and reduce the potential for adverse consequences.
Plastic packaging systems play an important role in protecting the drugs we use. However, a drug’s packaging must be compatible with the product and not compromise its stability, efficacy or safety. USP’s Desmond Hunt, Ph.D., provides insight into plastic packaging systems for drugs and how USP standards can support quality in this field.
Quality plays an integral role in connecting medical research and manufacturing to healthcare practice and consumers. The growing study of the microbiome and the potential health benefits of probiotics offers a particularly timely and illustrative example. Learn about the quality standards USP has developed for probiotics and how they could be the unifying thread connecting clinical research to academia, industry and patients/consumers.
Learn about and view the new suite of physical and written standards that USP is developing to help biologics manufacturers develop and analyze therapeutic proteins. New general chapters address analytical procedures for monoclonal antibodies, oligosaccharides, and protein determination.